AVADEL PHARMACEUTICALS - COM (AVDL)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM
Number of holders
99
Total Shares
52M
Shares change
+3.54M
Total reported value, excl. options
$856M
Value change
+$74.7M
Put/Call ratio
0.87
Number of buys
55
Number of sells
-39
Price
$16.48
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.